 LEXINGTON, Mass. and AMSTERDAM, The Netherlands, April 28, 2021 GLOBE NEWSWIRE -- uniQure N.V. NASDAQ: QURE, a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced that five data presentations, of which two are oral presentations, will be delivered at the American Society of Gene and Cell Therapy ASGCT Virtual 2021 Annual Meeting being held May 11-14. 